Brought to you by 
Ironwood Pharmaceuticals nets $203mm in IPO
08 Mar 2010
Executive Summary
Ironwood Pharmaceuticals (mainly gastrointestinal diseases) sold 19.2mm Class A common shares (including the overallotment) at $11.25 to net $203mm in its initial public offering. The share price fell below the company's expected $14-16 range, announced in January.
Deal Industry
- Biotechnology
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- IPO
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ironwood Pharmaceuticals nets $203mm in IPO
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice